The Middle East & Africa arterial blood gas kits market was valued at US$ 23,511.30 thousand in 2023 and is expected to reach US$ 40,859.41 thousand by 2031; it is estimated to register a CAGR of 7.2% from 2023 to 2031.
Modern compact arterial blood gas analyzers have the potential to enhance workflow efficiency and improve patient outcomes by facilitating prompt diagnosis and treatment initiation. The kits leverage advanced technologies to provide precise measurements, quality assurance features, and connectivity options for data management and integration with electronic medical records (EMR). Further, arterial blood gas kits can be equipped with wireless connectivity options, due to which they can be seamlessly integrated with the EMR of a hospital information system (HIS). Integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. The burgeoning popularity of telehealth and remote monitoring activities further encourages companies to focus on developing kits that are user-friendly so that they can reduce human errors and improve the overall usability of the product. They are incorporating automated quality control mechanisms and calibration processes in kits to minimize errors and maintain consistent performance of kits. The companies may also integrate kits with safety features such as sample volume monitoring, built-in error detection algorithms, and automatic system checks to ensure the reliability of arterial blood gas kits. In addition, arterial blood gas kits can be introduced with integrated sensors and analyzers that can easily and accurately measure parameters such as partial pressure of oxygen (pO2), electrolytes, partial pressure of carbon dioxide (pCO2), and pH. Thus, the development of user-friendly and automated kits, and the integration of EMR with them are likely to emerge as a notable trend in the arterial blood gas kits market in the future.
Healthcare service providers, public organizations, and government bodies in Saudi Arabia have been initiating programs to support the development of arterial blood gas kits and promote their use in the country. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia owing to rising investments, which help in the development of healthcare facilities and infrastructure in the country. Moreover, the Saudi Vision 2030 program of the Government of Saudi Arabia, launched to reduce oil dependence on oil and diversify the economy, benefits various healthcare segments, which is likely to favor the arterial blood gas kits market growth in the country in the future. Saudi Arabia, one of the fastest developing economies with a large population base in the Middle East & Africa, reports a rising chronic and respiratory disease prevalence. The private sector is also increasingly delivering health care services in the country. As per data published by the National Institute of Health in 2022, ~434,561 individuals suffered from COPD in Saudi Arabia, recording an increase of 329.82% from 1990. Greater awareness of health issues and increasing availability of healthcare services propels the demand for different types of medical equipment, including arterial blood gas kits. The Government of Saudi Arabia is also offering several incentives to promote the domestic manufacturing of medical devices, which drives the arterial blood gas kits market growth in the country.
Strategic insights for the Middle East & Africa Arterial Blood Gas Kits provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Middle East & Africa Arterial Blood Gas Kits refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Middle East & Africa Arterial Blood Gas Kits Strategic Insights
Middle East & Africa Arterial Blood Gas Kits Report Scope
Report Attribute
Details
Market size in 2023
US$ 23,511.30 thousand
Market Size by 2031
US$ 40,859.41 thousand
Global CAGR (2023 - 2031)
7.2%
Historical Data
2025-2031
Forecast period
2021-2023
Segments Covered
By Syringe Type
By Type
By Usage
By Application
By Pathogen
Regions and Countries Covered
Middle East and Africa
Market leaders and key company profiles
Middle East & Africa Arterial Blood Gas Kits Regional Insights
The Middle East & Africa arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.
Based on syringe type, the Middle East & Africa arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.
In terms of type, the Middle East & Africa arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.
By usage, the Middle East & Africa arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.
Based on application, the Middle East & Africa arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.
In terms of needle gauge, the Middle East & Africa arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.
Based on syringe volume, the Middle East & Africa arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.
By end user, the Middle East & Africa arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.
Based on country, the Middle East & Africa arterial blood gas kits market is segmented into South Africa, Saudi Arabia, the UAE, Kuwait, Qatar, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa arterial blood gas kits market share in 2023.
Radiometer Medical ApS, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd. are among the leading companies operating in the Middle East & Africa arterial blood gas kits market.
The Middle East & Africa Arterial Blood Gas Kits Market is valued at US$ 23,511.30 thousand in 2023, it is projected to reach US$ 40,859.41 thousand by 2031.
As per our report Middle East & Africa Arterial Blood Gas Kits Market, the market size is valued at US$ 23,511.30 thousand in 2023, projecting it to reach US$ 40,859.41 thousand by 2031. This translates to a CAGR of approximately 7.2% during the forecast period.
The Middle East & Africa Arterial Blood Gas Kits Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Arterial Blood Gas Kits Market report:
The Middle East & Africa Arterial Blood Gas Kits Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Arterial Blood Gas Kits Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Arterial Blood Gas Kits Market value chain can benefit from the information contained in a comprehensive market report.